Post by cave76 on Oct 28, 2007 18:45:04 GMT -8
"This new division researches the five pathogens that will most likely be used by terrorists as weapons - plague, tularemia, and Venezuelan, western and eastern equine encephalitis viruses, and develops emergency response plans for epidemics - natural or terrorist. The CDC and Colorado State partnership also investigates dengue fever, West Nile virus, Japanese encephalitis, yellow fever, Lyme disease, tick-borne relapsing fever and tularemia, human plague and others."
ghrc.colostate.edu/index.asp
Global Health Research at Foothills Campus Protecting the world against infectious disease and bioterrorism is a serious challenge. Infectious diseases are the leading cause of death worldwide and the third leading cause of death in the United States.
If used as a terrorist tool on an unprepared public, the numbers could only rise.
Colorado State University is increasingly responsible for developing sophisticated technology, advancing research and creating responses to these threats. With federal and private partners, we aggressively tackle these challenges at our Judson M. Harper Research Complex on our Foothills Campus. Our strong foundation and history of excellence in infectious disease research is being enhanced with more than $150 million in new facilities, further cementing the campus as the leading international infectious disease research site.
Regional Biocontainment Laboratory
Our cutting-edge biomedical research at the complex was bolstered with the fall 2005 groundbreaking for a $22 million Regional Biocontainment Laboratory, funded primarily by a grant from the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health. The RBL is level-three security laboratory where researchers can find ways to prevent, diagnose and cure infectious diseases that sicken people around the world and prevent and counteract bioterrorism. It provides advanced research capacity and provides facilities for our collaborations with the nation's best government, academia and industry scientists in these fields.
Rocky Mountain Regional Center of Excellence In June 2005, Colorado State clinched a four-year, $40 million grant, also from NIAID, to establish a Regional Center of Excellence for Biodefense and Emerging Infectious Diseases research and training. The Rocky Mountain RCE, which includes Colorado, Montana, North Dakota, South Dakota, Utah and Wyoming, is a multi-disciplinary research and training center. It furthers our world-recognized commitment to meeting our nation's need for new vaccines, diagnostics and medicines for infectious diseases and prevent bioterrorism.
Vector-Borne Infectious Diseases Research Also on the campus, the Centers for Disease Control and Prevention has housed its new $80 million state-of-the-art Division of Vector-Borne Infectious Diseases, showcasing just one of the university's federal research partnerships to address these threats. This new division researches the five pathogens that will most likely be used by terrorists as weapons - plague, tularemia, and Venezuelan, western and eastern equine encephalitis viruses, and develops emergency response plans for epidemics - natural or terrorist. The CDC and Colorado State partnership also investigates dengue fever, West Nile virus, Japanese encephalitis, yellow fever, Lyme disease, tick-borne relapsing fever and tularemia, human plague and others. Our 40-year partnership has produced a multitude of infectious disease research prevention and treatment breakthroughs.
The Ongoing Commitment from Colorado State University These new facilities complement research already conducted at our Bioenvironmental Research Building and its Arthropod-borne and Infectious Diseases Laboratory. Colorado State also recently invested $10 million in faculty positions and state-of-the-art resources in its Biomedical Excellence Initiative research program, and has received millions in grants for tuberculosis, dengue fever, West Nile virus and plague research to improve the health of people around the world.
ghrc.colostate.edu/index.asp
Global Health Research at Foothills Campus Protecting the world against infectious disease and bioterrorism is a serious challenge. Infectious diseases are the leading cause of death worldwide and the third leading cause of death in the United States.
If used as a terrorist tool on an unprepared public, the numbers could only rise.
Colorado State University is increasingly responsible for developing sophisticated technology, advancing research and creating responses to these threats. With federal and private partners, we aggressively tackle these challenges at our Judson M. Harper Research Complex on our Foothills Campus. Our strong foundation and history of excellence in infectious disease research is being enhanced with more than $150 million in new facilities, further cementing the campus as the leading international infectious disease research site.
Regional Biocontainment Laboratory
Our cutting-edge biomedical research at the complex was bolstered with the fall 2005 groundbreaking for a $22 million Regional Biocontainment Laboratory, funded primarily by a grant from the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health. The RBL is level-three security laboratory where researchers can find ways to prevent, diagnose and cure infectious diseases that sicken people around the world and prevent and counteract bioterrorism. It provides advanced research capacity and provides facilities for our collaborations with the nation's best government, academia and industry scientists in these fields.
Rocky Mountain Regional Center of Excellence In June 2005, Colorado State clinched a four-year, $40 million grant, also from NIAID, to establish a Regional Center of Excellence for Biodefense and Emerging Infectious Diseases research and training. The Rocky Mountain RCE, which includes Colorado, Montana, North Dakota, South Dakota, Utah and Wyoming, is a multi-disciplinary research and training center. It furthers our world-recognized commitment to meeting our nation's need for new vaccines, diagnostics and medicines for infectious diseases and prevent bioterrorism.
Vector-Borne Infectious Diseases Research Also on the campus, the Centers for Disease Control and Prevention has housed its new $80 million state-of-the-art Division of Vector-Borne Infectious Diseases, showcasing just one of the university's federal research partnerships to address these threats. This new division researches the five pathogens that will most likely be used by terrorists as weapons - plague, tularemia, and Venezuelan, western and eastern equine encephalitis viruses, and develops emergency response plans for epidemics - natural or terrorist. The CDC and Colorado State partnership also investigates dengue fever, West Nile virus, Japanese encephalitis, yellow fever, Lyme disease, tick-borne relapsing fever and tularemia, human plague and others. Our 40-year partnership has produced a multitude of infectious disease research prevention and treatment breakthroughs.
The Ongoing Commitment from Colorado State University These new facilities complement research already conducted at our Bioenvironmental Research Building and its Arthropod-borne and Infectious Diseases Laboratory. Colorado State also recently invested $10 million in faculty positions and state-of-the-art resources in its Biomedical Excellence Initiative research program, and has received millions in grants for tuberculosis, dengue fever, West Nile virus and plague research to improve the health of people around the world.
